期刊文献+

疫苗微粒鼻腔给药系统的研究进展 被引量:3

Development of Research on Vaccine Microparticle Nasal Drug Delivery System
在线阅读 下载PDF
导出
摘要 疫苗微粒鼻腔给药作为一种新型非侵入性疫苗给药系统,具有能延长免疫时间、增强免疫效果、提高病人顺应性等优点。综述疫苗鼻腔免疫诱导机制、常用的微粒系统、免疫效果影响因素及其评价方法及目前该给药系统存在的问题,旨在为研究开发疫苗微粒鼻腔给药系统提供新的思路和方法。 Vaccine microparticle nasal drug delivery system is a new non-invasive vaccine delivery system which possesses some advantages, such as extending immunization time, enhancing immune response and elevating patients' compliance, This article reviews the mechanism of immunization and normal micreparticle system of the nasal vaccination, and the factors affecting irnrntmizing effectiveness, evaluating method and existing problems for it, so that the strategies and methods for the further investigations are provided.
出处 《药学进展》 CAS 2007年第9期391-397,共7页 Progress in Pharmaceutical Sciences
基金 国家自然科学基金资助项目(30371781)
关键词 疫苗 微粒 鼻腔给药系统 Vaccine Microparticle Nasal drug delivery system
  • 相关文献

参考文献33

  • 1Alpar H O,Somavarapu S,Atuah K N,et al.Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery[J].Adv Drug Deliv Rev,2005,57(3):411-430.
  • 2Belshe R B.Current status of live attenuated influenza virus vaccine in the US[J].Virus Res,2004,103(1-2):177-185.
  • 3冯健,李范珠.促蛋白多肽类药物经鼻黏膜吸收的研究进展[J].中国药学杂志,2005,40(15):1128-1130. 被引量:9
  • 4Partidos C D.Intranasal vaccines:forthcoming challenges[J].Pharm Sci Technol Today,2000,3(8):273-281.
  • 5Gutierro I,Hernandez R M,Igartua M,et al.Influence of dose and immunization route on the serum IgG antibody response to BSA loaded PLGA microspheres[J].Vaccine,2002,20(17-18):2181-2190.
  • 6Ugwoke M I,Aqu R U,Verbeke N,et al.Nasal mucoadhesive drug delivery:Background,applications,trends and future perspectives[J].Adv Drug Deliv Rev,2005,57(11):1640-1665.
  • 7Illum L,Jabbal-Gill I,Hinchcliffe M,et al.Chitosan as a novel nasal delivery system for vaccines[J].Adv Drug Deliv Rev,2001,51(1-3):81-96.
  • 8Davis S S.Nasal vaccines[J].Adv Drug Deliv Rev,2001,51(1-3):21-42.
  • 9Illum L.Nanoparticulate systems for nasal delivery of drugs:a real improvement over simple systems[J].J Pharm Sci,2007,96(3):473-483.
  • 10Tafaghodi M,Sajadi Tabassi S A,Jaafari M R.Induction of systemic and mucosal immune responses by intranasal administration of alginate microspheres encapsulated with tetanus toxoid and CpG-ODN[J].Inter J Pharm,2006,319(1-2):37-43.

二级参考文献24

  • 1Chang SF, Chien YW. Intranasal drug administration for systemic medication[ J]. Pharm Int, 1984,5:287.
  • 2Lipworth BJ, Jackson CM. Safety of inhaled and intranasal corticosteroids: lessons for the new millennium[ J]. Drug Saf, 2000,23:11.
  • 3Illum L. Nasal drug delivery: posibilities, problems and solutions[J].J Controlled Release ,2003,87:187.
  • 4Illum L. Chitosan and its use as a pharmaceutical excipient[J].Pharm Res, 1998,15(9): 1326.
  • 5Shahiwala A, Misra A. Nasal delivery of levonorgestrel for contraception:an experimental study in rats[J]. FertilSteril,2004,81(Suppl 1):893.
  • 6Schipper NGM, Olsson S, Hoogstraate JA, et al. Chitosan as absorption enhancers for poorly absorbed drugs 2: mechanisms of absorption enhancement[J]. Pharm Res, 1997,14(7) :923.
  • 7Dodane V, Khan MA, Merwin JR. Effect of chitosan on epithelial permeability and structure[J]. Int J Pharm, 1999, 182:21.
  • 8Chan V, Mao HQ, Leong KW. Chitosan-induced perturbation of dipalmitoyl-sn-glycero-3-phosphocholine membrane bilayer [ J ]. Langmuir, 2001,17: 3749.
  • 9Lim ST, Forbes B, Martin GP, et al. Invivo and invitro characterization of novel microparticulates based on hyaluronan and chitosan hydroglutamate [ J ] . AAPS Pharm Sci Tech ,2001,2(4) :20.
  • 10Dyer AM, Hinchcliffe M, Watts P, et al. Nasal delivery of insulin using novel chitosan based formulations: a comparative study in two animal models between simple chitosan formulations and chitosan nanoparticles [ J ]. Pharm Res, 2002,19 ( 7 ): 998.

共引文献8

同被引文献47

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部